Switzerland's first pilot project for the legal sale of cannabis products has been delayed after some of the initial stock failed quality control tests.
This content was published on
2 minutes
swissinfo.ch/mga
Русский
ru
Начало легальной продажи марихуаны в Базеле отложено
The ‘Weed Care’ experiment in the city of Basel was supposed to launch on September 15. But it has been put on hold because traces of pesticides were found in some of the supposedly organic plants.
Basel’s health department said on Friday that the delay could last several weeks or even months as products must now be analysed again by an independent body.
Six cannabinoid products – four types of cannabis flowers and two types of hashish – were due to go on sale in nine pharmacies from next week.
The Federal Office of Public Health approved the pilot scheme in April as part of a project by the University of Basel, its psychiatric clinics and the cantonal health department.
It is intended to help evaluate the effects of new regulations on the recreational use of cannabis and ultimately combat black market distribution.
Pilot sale over-subscribed
Several other local authorities, including Zurich, Geneva and Bern, have also applied to roll out similar trials. The Swiss parliament laid the legal basis for such small-scale initiatives in September 2020.
The Basel pilot, which will allow 370 people to participate in the sale of approved products, is over-subscribed with 700 applications.
Basel health officials will now consider options, including different products from the official supplier or even examining different potential suppliers.
The recreational use of cannabis remains banned in Switzerland but it can be consumed for medical reasons. In 2008, voters rejected a proposal to decriminalise cannabis consumption.
More
More
Swiss cannabis market – a delicate balancing act
This content was published on
Producing and selling hemp inflorescences with low THC content has been legal in Switzerland since 2017. But the market hasn’t been a gold mine.
In banking, Switzerland can’t afford ‘model pupil syndrome’, says UBS CEO
This content was published on
UBS Group CEO Sergio Ermotti says competition between banks in Switzerland will continue even following the takeover of rival Credit Suisse.
Switzerland to chair international forum on migration
This content was published on
Switzerland will chair the Intergovernmental Consultations on Asylum, Refugees and Migration (IGC) in 2025, the government announced on Monday.
Y2K anniversary: Swiss preparations to dodge the millennium bug
This content was published on
The idea that computers around the world could fail at midnight on December 31, 1999 put many on alert. In the end, not much went wrong.
‘Switzerland needs a stable relationship with its neighbours,’ says foreign minister
This content was published on
"We are once again entering an 'America first, Europe first, Switzerland first' logic," Ignazio Cassis said in an interview published Monday.
Jimmy Carter supported Swiss-backed peace effort for Middle East
This content was published on
Former United States President Jimmy Carter maintained close ties with Switzerland and had expressed gratitude for the country's efforts on the Geneva peace initiative.
Swiss cowfighting championship at risk of being cancelled
This content was published on
Despite growing popularity, the national Hérens cowfighting championship could be cancelled in 2025 for lack of organisers.
Health office approves first Swiss project to sell cannabis for recreational use
This content was published on
The city of Basel is the first to be given the green light by the Swiss authorities for a scientific trial with cannabis for recreational use.
Legal marijuana could earn millions for Swiss state
This content was published on
Some 130 firms have registered with the Swiss federal authorities to sell legal pot that could generate CHF30 million ($30.2 million) in revenue.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.